Nitric oxide suppresses bFGF- and IL-1-alpha-mediated but not VEGF165-mediated angiogenesis in natively vascularized mammalian tissue

APMIS

Volumn 106, Issue 12, 1998, Pages 1142-1148

  Norrby, Klas ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Angiogenesis; bFGF; IL 1; L NAME; Nitric oxide; Quantification; Rat; VEGF165

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; INTERLEUKIN 1ALPHA; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL DENSITY; ENZYME INHIBITION; IMAGE ANALYSIS; INHIBITION KINETICS; MALE; MORPHOMETRICS; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0032451262     PISSN: 09034641     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1699-0463.1998.tb00270.x     Document Type: Article

References (28)

1. Bassenge, E.: Endothelial function in different organs. Prog. Cardiovasc. Dis. 34: 209-228, 1996.
2. Blitzer, M. L., Lee, S. D. & Creager, M. A.: Endothelium-derived nitric oxide mediates hypoxic vasodilation of resistance vessels in humans. Am. J. Physiol. 271: H1182-H1185, 1996.
3. Bull, H. A., Hothersall, J., Chowghury, N., Cohen, J. & Dowd, P. M.: Neuropeptides induce release of nitric oxide from human dermal microvascular endothelial cells. J. Invest. Dermatol. 106: 655-660, 1996.
4. Cockerill, G. W., Gamble, J. R. & Vadas, M. A.: Angiogenesis: Models and modulators. Int. Rev. Cytol. 159: 113-160, 1995.
5. Crane, B. R., Arvai, A. S. & Gachhui, R. et al.: The structure of nitric oxide synthase oxygenase domain and inhibitor complexes. Science 278: 425-431, 1997.
6. D'Amato, R.: Quantification of angiogenesis inhibitors in animal models. In: Hori, W. (Ed.): Therapeutic implications and mechanisms of angiogenesis - inhibitors and stimulators. Southborough: IBC's Library Series 1996: 1.2.1-1.2.8.
7. Friedlander, M., Brooks, P. C., Shaffer, R. W., Kincaid, C. M., Varner, J. A. & Cheresh, D. A.: Definition of two angiogenic pathways by distinct v integrins. Science 270: 1500-1502, 1995.
8. Galley, H. F., Walker, B. E., Howgle, P. D. & Webster, N. R.: Regulation of nitric oxide synthase activity in cultured human endothelial cells: Effect of antioxidants. Free Rad. Biol. Med. 21: 97-101, 1996.
9. Harrison, D. G., Sayegh, H., Ohara, Y., Inoue, N. & Venema, R. C.: Regulation of expression of the endothelial cell nitric oxide synthase. Clin. Exp. Pharmacol. Physiol. 23: 251-255, 1996.
10. Kodama, T., Marmon, L. M., Vargas, R., Farhat, M., Hoy, G. R. & Ramwell, P. W.: The interaction between endothelium-derived relaxing factor (EDRF) and eicosanoids in the regulation of the mesenteric microcirculation. J. Surg. Res. 58: 227-232, 1995.
11. Leibovich, S. J., Polverini, P. J., Fong, T. W., Harlow, L. A. & Koch, A., E.: Production of angiogenic activity by human monocytes requires an L-arginine/nitric oxide-synthase-dependent effector mechanism. Proc. Natl. Acad. Sci. USA 91: 4190-4194, 1994.
12. Murohara, T., Horowitz, J. R., Silver, M., Tsurumi, Y., Chen, D., Sullivan, A. & Isner, J. M.: Vascular endothelial growth factor/vascular permeability factor enhances vascular permeability via nitric oxide and prostacyclin. Circulation 97: 99-107, 1998.
13. Norrby, K.: Basic fibroblast growth factor and de novo mammalian angiogenesis. Microvasc. Res. 48: 96-113, 1994.
14. Norrby, K.: Vascular endothelial growth factor and de novo mammalian angiogenesis. Microvasc. Res. 51: 153-163, 1996.
15. Norrby, K.: Angiogenesis: New aspects relating to its initiation and control. APMIS 105: 417-437, 1997.
16. Norrby, K.: Interleukin-1-alpha and de novo mammalian angiogenesis. Microvasc. Res. 54: 58-64, 1997.
17. Norrby, K.: Microvascular density in terms of number and length of microvessel segments per unit tissue volume in mammalian angiogenesis. Microvasc. Res. 55: 43-53, 1998.
18. Norrby, K., Jakobsson, A. & Sörbo, J.: Quantitative angiogenesis in spreads of intact rat mesenteric windows. Microvasc. Res. 39: 341-348, 1990.
19. Norrby, K. & Østergaard, P.: Basic FGF-mediated de novo angiogenesis is more effectively suppressed by low-molecular-weight heparin than by high-molecular-weight heparin. Int. J. Microcirc. 16: 8-15, 1996.
20. Pipili-Synetos, E., Sakkoula, E. & Maragoudakis, M. E.: Nitric oxide is involved in the regulation of angiogenesis. Br. J. Pharmacol. 108: 855-857, 1993.
21. Pipili-Synetos, E., Sakkoula, E., Haralabopoulos, G., Andriopuolou, P., Peristeris, P. & Maragoudakis, M. E.: Evidence that nitric oxide is an endogenous antiangiogenic mediator. Br. J. Pharmacol. 111: 894-902, 1994.
22. Pipili-Synetos, E., Papageorgiou, A. & Sakkoula, E. et al.: Inhibition of angiogenesis, tumour growth and metastasis by the NO-releasing vasodilators, isosorbide mononitrate and dinitrate. Br. J. Pharmacol. 116: 1829-1834, 1995.
23. Sakkoula, E., Pipili-Synetos, E. & Maragoudakis, M. E.: Involvement of nitric oxide in the inhibition of angiogenesis by interleukin-2. Br. J. Pharmacol. 122: 793-795, 1997.
24. Tamura, T., Nakanishi, T. & Kimura, Y. et al.: Nitric oxide mediates interleukin-1-induced matrix degradation and basic fibroblast growth factor release in cultured rabbit articular chondrocytes: A possible mechanism of pathological neovascularization in arthritis. Endocrinology 137: 3729-3737, 1996.
25. Wilting, J. & Christ, B.: A morphological study of the rabbit corneal assay. Anat. Ann. 174: 549-556, 1992.
26. Ziche, M., Morbidelli, L., Masini, E. et al.: Nitric oxide mediates angiogenesis in vivo and endothelial cell growth and migration in vitro promoted by substance. P. J. Clin. Invest. 94: 2036-2044, 1994.
27. 1 in rabbit cornea. Adv. Prostaglandin Thromboxane Leukoc. Res. 23: 495-497, 1995.
28. Ziche, M., Morbidelli, L. & Choudhuri, R. et al.: Nitric oxide synthase lies downstream from vascular endothelial growth factor-induced angiogenesis. J. Clin. Invest. 99: 2625-2634, 1997.